Navigation Links
Nosey Camera Could Bring Relief to 4 Million Brits

LONDON, October 31, 2011 /PRNewswire/ --

New tools build upon company's minimally-invasive Balloon Sinuplasty™ Platform to improve visualisation capabilities during sinus surgery for the treatment of chronic rhinosinusitis.

Millions of patients in the UK who suffer from nasal and sinus problems could be brought relief by two innovative technologies to help clear nasal blockages.

Sinusitis is the most common sinus related illness in the UK, with around nine million sufferers and is caused when the delicate membranes in the sinus become inflamed, causing a blockage.

The symptoms of sinusitis can include: pressure headaches, facial pain, nasal obstruction, toothache and fatigue.

Two new technologies, the Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System, allow surgeons to navigate the sinus with an exceptional field of vision to check for any blockages or potential problems.

The sinuses are the air spaces behind the bones of the upper face, between the eyes and behind the forehead, nose and cheeks. The sinuses are narrow and tortuous anatomy, and even relatively minor inflammation can present a major obstacle.

Acclarent Cyclops™ Multi-Angle Endoscope and the Relieva Luma Sentry™ Sinus Illumination System allows the surgeon to directly visualise the natural opening of the sinuses, even parts which are just a few millimeters wide, and examine many angles with one scope.

The two innovations were developed by Acclarent, Inc. who also introduced Balloon Sinuplasty™, a technique in which a tiny balloon is guided into the sinuses to help clear blockages in the sinus in an effective manner.

The treatment has been hugely successful and since Balloon Sinuplasty was launched in 2005, more than 120,000 patients have been treated with the medical procedure.

For further information please visit

For more information on chronic sinusitis treatment visit: and for information on sinus surgery visit:

About the Balloon Sinuplasty™ System: Since 2005, more than 120,000 patients have been treated with Balloon Sinuplasty technology in operating rooms and office settings. Acclarent's comprehensive visualisation capabilities enable surgeons to confidently access, dilate and irrigate targeted sinuses throughout every aspect of Endoscopic Sinus Surgery (ESS) with Balloon Sinuplasty technology and provide their patients with minimally invasive options that have been repeatedly proven safe and effective worldwide.

Acclarent, Inc.

Acclarent is a global medical technology company dedicated to the development of innovative products to further meet the needs of ENT surgeons and their patients. Based in Menlo Park, Calif., the company operates as a business unit of Ethicon, Inc., a Johnson & Johnson company.  Through its core technologies and commitment to innovation, Acclarent will continue to advance novel technologies in all areas of ENT. Acclarent markets and sells its products worldwide and its technology has been used by thousands of physicians. For more information about Acclarent, visit

SOURCE Balloon Sinuplasty(TM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
2. MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras
3. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
4. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
5. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
6. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
7. Mayo Clinic Study Shows Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
8. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over ... More than 3.7 billion people under the age of 50 – or 67% of ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... ... Dr. Thomas Dunlap and Dr. Patrick Coleman , cardiologist ... Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted the ... ways and require time-critical intervention to avoid large area heart damage and progressive infections ...
Breaking Medicine News(10 mins):